Trupanion, Inc. (NASDAQ:TRUP – Get Free Report) COO John Gallagher sold 430 shares of the company’s stock in a transaction on Wednesday, January 28th. The shares were sold at an average price of $31.67, for a total transaction of $13,618.10. Following the sale, the chief operating officer owned 31,861 shares of the company’s stock, valued at $1,009,037.87. This represents a 1.33% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this hyperlink.
Trupanion Price Performance
Shares of Trupanion stock opened at $31.99 on Friday. The company’s fifty day simple moving average is $35.56 and its two-hundred day simple moving average is $41.29. Trupanion, Inc. has a 12-month low of $30.85 and a 12-month high of $57.88. The firm has a market cap of $1.38 billion, a PE ratio of 88.86 and a beta of 1.58. The company has a quick ratio of 1.71, a current ratio of 1.71 and a debt-to-equity ratio of 0.31.
Trupanion (NASDAQ:TRUP – Get Free Report) last posted its earnings results on Thursday, November 6th. The financial services provider reported $0.13 earnings per share for the quarter, missing analysts’ consensus estimates of $0.89 by ($0.76). The firm had revenue of $366.92 million for the quarter, compared to analysts’ expectations of $361.58 million. Trupanion had a return on equity of 4.48% and a net margin of 1.10%.The business’s revenue for the quarter was up 12.0% on a year-over-year basis. During the same quarter in the prior year, the company posted $0.03 earnings per share. As a group, equities analysts expect that Trupanion, Inc. will post 0.13 EPS for the current year.
Institutional Inflows and Outflows
Wall Street Analysts Forecast Growth
Several equities analysts have recently issued reports on TRUP shares. Cantor Fitzgerald reduced their target price on Trupanion from $50.00 to $42.00 and set a “neutral” rating on the stock in a research note on Wednesday, January 14th. Piper Sandler reduced their price objective on shares of Trupanion from $67.00 to $60.00 and set an “overweight” rating on the stock in a research report on Friday, December 19th. Wall Street Zen cut shares of Trupanion from a “buy” rating to a “hold” rating in a research report on Saturday, December 6th. Weiss Ratings reiterated a “sell (d+)” rating on shares of Trupanion in a research report on Monday, December 29th. Finally, Zacks Research upgraded shares of Trupanion from a “hold” rating to a “strong-buy” rating in a report on Tuesday, January 6th. One equities research analyst has rated the stock with a Strong Buy rating, two have issued a Buy rating, two have issued a Hold rating and one has issued a Sell rating to the company. According to data from MarketBeat, Trupanion presently has an average rating of “Moderate Buy” and a consensus price target of $50.00.
Get Our Latest Stock Report on TRUP
Trupanion Company Profile
Trupanion, Inc is a pet medical insurance company that provides comprehensive insurance coverage for cats and dogs. The company’s core offering is a single, customizable medical policy designed to cover veterinary diagnostic tests, surgeries, hospital stays and congenital or hereditary conditions. Trupanion seeks to streamline the claims process by offering direct payment options to participating veterinarians, reducing the need for upfront payments by pet owners.
Founded in 1999 by Darryl Rawlings and headquartered in Seattle, Washington, Trupanion began operations in the early 2000s and has grown its presence through both digital channels and partnerships with veterinary hospitals.
Recommended Stories
- Five stocks we like better than Trupanion
- Stock market legend warns: “An Ominous Day Is Coming for the Markets…”
- Another reason you need to own gold… [running out]
- Trump’s Final Shocking Act Begins February 24
- NEW: Gold makes history
- Deutsche Bank Just Raised Their Gold Target to $6,000
Receive News & Ratings for Trupanion Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Trupanion and related companies with MarketBeat.com's FREE daily email newsletter.
